Position in LLY
as of Jun 30, 2026
· filed Aug 19, 2026
Position Value
$1,574,851
+$449,973 QoQ
Shares Held
1,313
+7.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.69%
of 13F equity value
Holder Rank
#2,724
of 4,605 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Financial Avengers, Inc. holds $17,063,900 across 8 Drug Manufacturers - General names. LLY ranks #3 (9.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
47,625 | $12,095,321 | |
| 2 | PFE |
Pfizer Inc
|
131,989 | $3,178,294 | |
| 3 | LLY |
ELI LILLY & Co
This page
|
1,313 | $1,574,851 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
1,344 | $169,800 | |
| 5 | MRK |
Merck & Co., Inc.
|
132 | $16,962 | |
| 6 | ABBV |
AbbVie Inc.
|
50 | $12,582 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
141 | $8,124 | |
| 8 | AMGN |
Amgen Inc
|
22 | $7,966 |
All Filings in LLY
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,574,851 | 1,313 | Shares | Sole | 2026-08-19 | |
| 2026-03-31 | $1,124,878 | 1,223 | Shares | Sole | 2026-05-19 | |
| 2025-12-31 | $1,459,415 | 1,358 | Shares | Sole | 2026-03-04 | |
| 2025-09-30 | $1,084,223 | 1,421 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $1,231,657 | 1,580 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $1,307,415 | 1,583 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $1,123,260 | 1,455 | Shares | Sole | 2025-02-18 | |
| 2024-09-30 | $1,326,252 | 1,497 | Shares | Sole | 2024-11-18 | |
| 2024-06-30 | $1,526,470 | 1,686 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $266,840 | 343 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $199,358 | 342 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $183,698 | 342 | Shares | Sole | 2023-11-15 | |
| 2023-06-30 | $159,922 | 341 | Shares | Sole | 2023-08-07 | |
| 2023-03-31 | $116,762 | 340 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $124,019 | 339 | Shares | Sole | 2023-02-06 | |
| 2022-09-30 | $109,292 | 338 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $68,412 | 211 | Shares | Sole | 2022-08-16 | |
| 2022-03-31 | $126,861 | 443 | Shares | Sole | 2022-05-11 | |
| 2021-12-31 | $122,089 | 442 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $77,401 | 335 | Shares | Sole | 2021-11-01 | |
| 2021-06-30 | $76,659 | 334 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $62,211 | 333 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $55,886 | 331 | Shares | Sole | 2021-02-05 | |
| No filing history on record for this holder in this stock. | ||||||